Desq Long
Sign in

Company

Replimune Group, Inc.

REPL · CIK 0001737953

SEC FORM 4
$132,175.68

Replimune Group, Inc. (REPL)

Sale of 9,256 shares at $14.28 per share.

Reporting Person Hill Emily Luisa · Officer Title Chief Financial Officer · Transaction Code S

Traded Aug 17, 2026 · Disclosed Aug 19, 2026

Source: SEC Form 4 · 0001104659-26-098868 · filed 2026-08-19 · View filing →

SEC FORM 4
$98,987.04

Replimune Group, Inc. (REPL)

Sale of 7,632 shares at $12.97 per share.

Reporting Person Schwendenman Andrew · Officer Title Chief Accounting Officer · Transaction Code S

Traded Aug 10, 2026 · Disclosed Aug 12, 2026

Source: SEC Form 4 · 0001104659-26-095003 · filed 2026-08-12 · View filing →

SEC FORM 4
$148,467.59

Replimune Group, Inc. (REPL)

Sale of 11,447 shares at $12.97 per share.

Reporting Person Xynos Konstantinos · Officer Title Chief Medical Officer · Transaction Code S

Traded Aug 10, 2026 · Disclosed Aug 12, 2026

Source: SEC Form 4 · 0001104659-26-095006 · filed 2026-08-12 · View filing →

SEC FORM 4
$148,480.56

Replimune Group, Inc. (REPL)

Sale of 11,448 shares at $12.97 per share.

Reporting Person Hill Emily Luisa · Officer Title Chief Financial Officer · Transaction Code S

Traded Aug 10, 2026 · Disclosed Aug 12, 2026

Source: SEC Form 4 · 0001104659-26-095008 · filed 2026-08-12 · View filing →

SEC FORM 4
$510,252.77

Replimune Group, Inc. (REPL)

Sale of 39,341 shares at $12.97 per share.

Reporting Person Patel Sushil · Officer Title Chief Executive Officer · Transaction Code S

Traded Aug 10, 2026 · Disclosed Aug 12, 2026

Source: SEC Form 4 · 0001104659-26-095012 · filed 2026-08-12 · View filing →